Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-06-26 @ 5:50 AM
Study NCT ID:
NCT00044005
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
2002-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability Study of Drug to Treat Schizophrenia
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1050174
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None